{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T14:14:20Z","timestamp":1784297660799,"version":"3.55.0"},"reference-count":49,"publisher":"American Association for Cancer Research (AACR)","issue":"18","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>p53 is a tumor suppressor that prevents the emergence of transformed cells by inducing apoptosis or senescence, among other responses. Its functions are regulated tightly by posttranslational modifications. Here we show that Bruton's tyrosine kinase (BTK) is a novel modulator of p53. We found that BTK is induced in response to DNA damage and p53 activation. BTK induction leads to p53 phosphorylation, which constitutes a positive feedback loop that increases p53 protein levels and enhances the transactivation of its target genes in response to stress. Inhibiting BTK reduced both p53-dependent senescence and apoptosis. Further, BTK expression also upregulated DNA damage signals and apoptosis. We conclude that despite being involved in oncogenic signals in blood malignancies, BTK has antineoplastic properties in other contexts, such as the enhancement of p53's tumor suppressor responses. Along with evidence that BTK expression correlates with good prognosis in some epithelial tumors, our findings may encourage a reevaluation of the clinical uses of BTK inhibitors in cancer therapy. Cancer Res; 76(18); 5405\u201314. \u00a92016 AACR.<\/jats:p>","DOI":"10.1158\/0008-5472.can-16-0690","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T22:43:50Z","timestamp":1469573030000},"page":"5405-5414","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["BTK Modulates p53 Activity to Enhance Apoptotic and Senescent Responses"],"prefix":"10.1158","volume":"76","author":[{"given":"Mohammad","family":"Althubiti","sequence":"first","affiliation":[{"name":"1Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester, United Kingdom."},{"name":"2Cancer Research UK Leicester Centre, Leicester, United Kingdom."},{"name":"3Department of Biochemistry, Faculty of Medicine, Umm Al-Qura University, Mecca, Saudi Arabia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miran","family":"Rada","sequence":"additional","affiliation":[{"name":"1Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester, United Kingdom."},{"name":"2Cancer Research UK Leicester Centre, Leicester, United Kingdom."},{"name":"4Department of Biology, School of Science, Faculty of Science and Education Sciences, University of Sulaimani, Sulaimaniyah, Kurdistan Region, Iraq."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesvin","family":"Samuel","sequence":"additional","affiliation":[{"name":"1Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester, United Kingdom."},{"name":"2Cancer Research UK Leicester Centre, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M.","family":"Escorsa","sequence":"additional","affiliation":[{"name":"1Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester, United Kingdom."},{"name":"2Cancer Research UK Leicester Centre, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hishyar","family":"Najeeb","sequence":"additional","affiliation":[{"name":"2Cancer Research UK Leicester Centre, Leicester, United Kingdom."},{"name":"5Department of Cancer Studies, University of Leicester, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon-Guan","family":"Lee","sequence":"additional","affiliation":[{"name":"6Bioprocessing Technology Institute, A*STAR, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kong-Peng","family":"Lam","sequence":"additional","affiliation":[{"name":"6Bioprocessing Technology Institute, A*STAR, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George D.D.","family":"Jones","sequence":"additional","affiliation":[{"name":"2Cancer Research UK Leicester Centre, Leicester, United Kingdom."},{"name":"5Department of Cancer Studies, University of Leicester, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nickolai A.","family":"Barlev","sequence":"additional","affiliation":[{"name":"7Institute of Cytology, RAS, Saint-Petersburg, Russia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvador","family":"Macip","sequence":"additional","affiliation":[{"name":"1Mechanisms of Cancer and Aging Laboratory, Department of Molecular and Cell Biology, University of Leicester, Leicester, United Kingdom."},{"name":"2Cancer Research UK Leicester Centre, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2016,9,15]]},"reference":[{"key":"2022061706181037100_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/358015a0","article-title":"Cancer. p53, guardian of the genome","volume":"358","author":"Lane","year":"1992","journal-title":"Nature"},{"key":"2022061706181037100_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","article-title":"p53 in health and disease","volume":"8","author":"Vousden","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061706181037100_bib3","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.18632\/oncotarget.1436","article-title":"Lysine-specific modifications of p53: a matter of life and death?","volume":"4","author":"Marouco","year":"2013","journal-title":"Oncotarget"},{"key":"2022061706181037100_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrm2451","article-title":"A complex barcode underlies the heterogeneous response of p53 to stress","volume":"9","author":"Murray-Zmijewski","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061706181037100_bib5","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.molmed.2010.09.002","article-title":"p53 post-translational modification: deregulated in tumorigenesis","volume":"16","author":"Dai","year":"2010","journal-title":"Trends Mol Med"},{"key":"2022061706181037100_bib6","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S1097-2765(01)00414-2","article-title":"Acetylation of p53 activates transcription through recruitment of coactivators\/histone acetyltransferases","volume":"8","author":"Barlev","year":"2001","journal-title":"Mol Cell"},{"key":"2022061706181037100_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nature03117","article-title":"Regulation of p53 activity through lysine methylation","volume":"432","author":"Chuikov","year":"2004","journal-title":"Nature"},{"key":"2022061706181037100_bib8","doi-asserted-by":"crossref","first-page":"6756","DOI":"10.1128\/MCB.00460-07","article-title":"Methylation-acetylation interplay activates p53 in response to DNA damage","volume":"27","author":"Ivanov","year":"2007","journal-title":"Mol Cell Biol"},{"key":"2022061706181037100_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc3430","article-title":"MDM2, MDMX, and p53 in oncogenesis and cancer therapy","volume":"13","author":"Wade","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"2022061706181037100_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0955-0674(00)00201-5","article-title":"DNA-PK, ATM, and ATR as sensors of DNA damage: variations on a theme?","volume":"13","author":"Durocher","year":"2001","journal-title":"Curr Opin Cell Biol"},{"key":"2022061706181037100_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/ncb1337","article-title":"ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks","volume":"8","author":"Jazayeri","year":"2006","journal-title":"Nat Cell Biol"},{"key":"2022061706181037100_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc2772","article-title":"Senescence in tumors: evidence from mice and humans","volume":"10","author":"Collado","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"2022061706181037100_bib13","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrm2233","article-title":"Cellular senescence: when bad things happen to good cells","volume":"8","author":"Campisi","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061706181037100_bib14","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/436642a","article-title":"Tumour biology: senescence in premalignant tumours","volume":"436","author":"Collado","year":"2005","journal-title":"Nature"},{"key":"2022061706181037100_bib15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"Lopez-Otin","year":"2013","journal-title":"Cell"},{"key":"2022061706181037100_bib16","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/361226a0","article-title":"The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases","volume":"361","author":"Vetrie","year":"1993","journal-title":"Nature"},{"key":"2022061706181037100_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.cellsig.2010.03.001","article-title":"The Src, Syk, and Tec family kinases: distinct types of molecular switches","volume":"22","author":"Bradshaw","year":"2010","journal-title":"Cell Signal"},{"key":"2022061706181037100_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1126\/science.271.5250.822","article-title":"Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases","volume":"271","author":"Rawlings","year":"1996","journal-title":"Science"},{"key":"2022061706181037100_bib19","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1128\/MCB.06620-11","article-title":"Regulation of nucleocytoplasmic shuttling of Bruton's tyrosine kinase (BTK) through a novel SH3-dependent interaction with ankyrin repeat domain 54 (ANKRD54)","volume":"32","author":"Gustafsson","year":"2012","journal-title":"Mol Cell Biol"},{"key":"2022061706181037100_bib20","doi-asserted-by":"crossref","first-page":"6287","DOI":"10.1182\/blood-2011-01-328484","article-title":"Bruton's tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765","volume":"117","author":"Herman","year":"2011","journal-title":"Blood"},{"key":"2022061706181037100_bib21","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1182\/blood-2013-02-482125","article-title":"Egress of CD19(+)CD5(+) cells into peripheral blood following treatment with the Bruton tyrosine kinase inhibitor ibrutinib in mantle cell lymphoma patients","volume":"122","author":"Chang","year":"2013","journal-title":"Blood"},{"key":"2022061706181037100_bib22","doi-asserted-by":"crossref","first-page":"3456","DOI":"10.1172\/JCI61188","article-title":"Molecular pathogenesis of multiple myeloma and its premalignant precursor","volume":"122","author":"Kuehl","year":"2012","journal-title":"J Clin Invest"},{"key":"2022061706181037100_bib23","doi-asserted-by":"crossref","first-page":"13075","DOI":"10.1073\/pnas.1004594107","article-title":"The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy","volume":"107","author":"Honigberg","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706181037100_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1177\/2040620714539906","article-title":"Bruton's tyrosine kinase inhibitors and their clinical potential in the treatment of B-cell malignancies: focus on ibrutinib","volume":"5","author":"Aalipour","year":"2014","journal-title":"Ther Adv Hematol"},{"key":"2022061706181037100_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nchembio.481","article-title":"Specific BTK inhibition suppresses B cell- and myeloid cell-mediated arthritis","volume":"7","author":"Di Paolo","year":"2011","journal-title":"Nat Chem Biol"},{"key":"2022061706181037100_bib26","doi-asserted-by":"crossref","first-page":"e1528","DOI":"10.1038\/cddis.2014.489","article-title":"Characterization of novel markers of senescence and their prognostic potential in cancer","volume":"5","author":"Althubiti","year":"2014","journal-title":"Cell Death Dis"},{"key":"2022061706181037100_bib27","doi-asserted-by":"crossref","first-page":"8576","DOI":"10.1128\/MCB.23.23.8576-8585.2003","article-title":"Influence of induced reactive oxygen species in p53-mediated cell fate decisions","volume":"23","author":"Macip","year":"2003","journal-title":"Mol Cell Biol"},{"key":"2022061706181037100_bib28","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/j.1365-2141.2007.06717.x","article-title":"CD154 induces a switch in pro-survival Bcl-2 family members in chronic lymphocytic leukaemia","volume":"138","author":"Willimott","year":"2007","journal-title":"Br J Haematol"},{"key":"2022061706181037100_bib29","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1073\/pnas.95.5.2509","article-title":"A simplified system for generating recombinant adenoviruses","volume":"95","author":"He","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061706181037100_bib30","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/onc.2013.119","article-title":"PPISURV: a novel bioinformatics tool for uncovering the hidden role of specific genes in cancer survival outcome","volume":"33","author":"Antonov","year":"2014","journal-title":"Oncogene"},{"key":"2022061706181037100_bib31","doi-asserted-by":"crossref","first-page":"13658","DOI":"10.1074\/jbc.M109.062562","article-title":"Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis","volume":"285","author":"Carrera","year":"2010","journal-title":"J Biol Chem"},{"key":"2022061706181037100_bib32","doi-asserted-by":"crossref","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","article-title":"A biomarker that identifies senescent human cells in culture and in aging skin in vivo","volume":"92","author":"Dimri","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061706181037100_bib33","doi-asserted-by":"crossref","first-page":"e97938","DOI":"10.1371\/journal.pone.0097938","article-title":"The role of the HIF-1alpha transcription factor in increased cell division at physiological oxygen tensions","volume":"9","author":"Carrera","year":"2014","journal-title":"PLoS One"},{"key":"2022061706181037100_bib34","doi-asserted-by":"crossref","first-page":"e953","DOI":"10.1038\/cddis.2013.483","article-title":"miR-16 and miR-26a target checkpoint kinases Wee1 and Chk1 in response to p53 activation by genotoxic stress","volume":"4","author":"Lezina","year":"2013","journal-title":"Cell Death Dis"},{"key":"2022061706181037100_bib35","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/cdd.2013.14","article-title":"Stra6, a retinoic acid-responsive gene","volume":"20","author":"Carrera","year":"2013","journal-title":"Cell Death Differ"},{"key":"2022061706181037100_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrc3702","article-title":"Targeting Bruton's tyrosine kinase in B cell malignancies","volume":"14","author":"Hendriks","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"2022061706181037100_bib37","doi-asserted-by":"crossref","first-page":"7644","DOI":"10.1038\/sj.onc.1203015","article-title":"Regulation of p53 in response to DNA damage","volume":"18","author":"Lakin","year":"1999","journal-title":"Oncogene"},{"key":"2022061706181037100_bib38","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1593\/neo.111512","article-title":"The dual PI3K\/mTOR inhibitor NVP-BEZ235 is a potent inhibitor of ATM- and DNA-PKCs-mediated DNA damage responses","volume":"14","author":"Mukherjee","year":"2012","journal-title":"Neoplasia"},{"key":"2022061706181037100_bib39","doi-asserted-by":"crossref","first-page":"6193","DOI":"10.1021\/jm901108b","article-title":"Discovery of 3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione (AEB071), a potent and selective inhibitor of protein kinase C isotypes","volume":"52","author":"Wagner","year":"2009","journal-title":"J Med Chem"},{"key":"2022061706181037100_bib40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.celrep.2015.01.039","article-title":"Bruton's tyrosine kinase phosphorylates DDX41 and activates its binding of dsDNA and STING to initiate type 1 interferon response","volume":"10","author":"Lee","year":"2015","journal-title":"Cell Rep"},{"key":"2022061706181037100_bib41","doi-asserted-by":"crossref","first-page":"9648","DOI":"10.1073\/pnas.94.18.9648","article-title":"Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53","volume":"94","author":"Sugrue","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"2022061706181037100_bib42","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nrm3823","article-title":"Cellular senescence: from physiology to pathology","volume":"15","author":"Munoz-Espin","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2022061706181037100_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2004-07-2708","article-title":"Tumor suppressor function of Bruton's tyrosine kinase is independent of its catalytic activity","volume":"105","author":"Middendorp","year":"2005","journal-title":"Blood"},{"key":"2022061706181037100_bib44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/(SICI)1521-2254(200005\/06)2:3<204::AID-JGM104>3.0.CO;2-5","article-title":"BTK mediated apoptosis, a possible mechanism for failure to generate high titer retroviral producer clones","volume":"2","author":"Islam","year":"2000","journal-title":"J Gene Med"},{"key":"2022061706181037100_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1084\/jem.20030615","article-title":"Bruton's tyrosine kinase cooperates with the B cell linker protein SLP-65 as a tumor suppressor in Pre-B cells","volume":"198","author":"Kersseboom","year":"2003","journal-title":"J Exp Med"},{"key":"2022061706181037100_bib46","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1074\/jbc.M308722200","article-title":"Bruton's tyrosine kinase phosphorylates cAMP-responsive element-binding protein at serine 133 during neuronal differentiation in immortalized hippocampal progenitor cells","volume":"279","author":"Yang","year":"2004","journal-title":"J Biol Chem"},{"key":"2022061706181037100_bib47","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0014-4827(61)90192-6","article-title":"The serial cultivation of human diploid strains","volume":"25","author":"Hayflick","year":"1961","journal-title":"Exp Cell Res"},{"key":"2022061706181037100_bib48","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/clpt.2012.193","article-title":"Senescent cells: a novel therapeutic target for aging and age-related diseases","volume":"93","author":"Naylor","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"2022061706181037100_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv020","article-title":"Effect of cellular senescence on the growth of HER2-positive breast cancers","volume":"107","author":"Zacarias-Fluck","year":"2015","journal-title":"J Natl Cancer Inst"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/18\/5405\/2742103\/5405.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/76\/18\/5405\/2742103\/5405.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T14:13:49Z","timestamp":1655475229000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/76\/18\/5405\/614142\/BTK-Modulates-p53-Activity-to-Enhance-Apoptotic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,15]]},"references-count":49,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2016,9,15]]},"published-print":{"date-parts":[[2016,9,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-16-0690","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22413891","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413897.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413894.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508845.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413900.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413894","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413897","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413891.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6508845","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22413900","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,15]]}}}